Tag Archives: MTP

Top 10 Blue Chip Stocks To Invest In Right Now

Shutterstock

A few weeks ago we discussed how you can make 12% annually, forever, from stocks. Now let’s apply those lessons to 2017, and highlight five that should do even better (17%+ returns) this year (and likely beyond).

Remember, projecting our returns from any given stock is simple. We simply add together the three ways it can pay us:

Its current dividend.

A future dividend hike.

Share repurchases.

It also helps if the stock is inexpensive, as buybacks deliver more bang for management’s buck. So let’s stick with stocks that are dirt-cheap, trading for 10-times free cash flow (FCF) or less for this exercise.

Here’s an example of a stock ready to return 17% or more over the next year. Blue chip refiner Valero (VLO) has a great management team that knows how to make money no matter what happens with energy prices.

Top 10 Blue Chip Stocks To Invest In Right Now: Nuveen Connecticut Premium Income Municipal Fund(NTC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Media stories about Nuveen Connecticut Premium Income Mun Fd (NYSE:NTC) have trended very positive recently, Accern Sentiment Analysis reports. The research firm identifies negative and positive news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Nuveen Connecticut Premium Income Mun Fd earned a news sentiment score of 0.53 on Accern’s scale. Accern also gave news stories about the investment management company an impact score of 47.4041994466706 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Top 10 Blue Chip Stocks To Invest In Right Now: Carpenter Technology Corporation(CRS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    ValuEngine cut shares of Carpenter Technology (NYSE:CRS) from a buy rating to a hold rating in a research note published on Monday morning.

    Other equities research analysts also recently issued reports about the company. Cowen reiterated a buy rating and issued a $66.00 target price on shares of Carpenter Technology in a research report on Friday, June 1st. Zacks Investment Research upgraded Carpenter Technology from a sell rating to a hold rating in a research report on Monday, April 16th. Deutsche Bank boosted their target price on Carpenter Technology from $47.00 to $49.00 and gave the stock a hold rating in a research report on Wednesday, April 11th. Finally, Longbow Research downgraded Carpenter Technology from a buy rating to a neutral rating and set a $50.00 target price on the stock. in a research report on Monday, June 25th. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. Carpenter Technology presently has an average rating of Hold and a consensus target price of $56.50.

  • [By Ethan Ryder]

    Titan International (NYSE: TWI) and Carpenter Technology (NYSE:CRS) are both industrial products companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings.

  • [By Logan Wallace]

    Carpenter Technology Co. (NYSE:CRS) VP Timothy Lain sold 1,007 shares of the firm’s stock in a transaction that occurred on Friday, May 4th. The stock was sold at an average price of $55.00, for a total transaction of $55,385.00. Following the completion of the transaction, the vice president now directly owns 11,288 shares of the company’s stock, valued at $620,840. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Top 10 Blue Chip Stocks To Invest In Right Now: State Bank Financial Corporation.(STBZ)

Advisors’ Opinion:

  • [By Logan Wallace]

    State Bank Financial (NASDAQ:STBZ) last issued its quarterly earnings results on Thursday, January 25th. The financial services provider reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.03. State Bank Financial had a return on equity of 9.26% and a net margin of 18.77%. The firm had revenue of $68.16 million during the quarter, compared to the consensus estimate of $65.00 million. analysts expect that State Bank Financial will post 2.18 EPS for the current year.

    TRADEMARK VIOLATION WARNING: “Analysts Set State Bank Financial (STBZ) PT at $34.00” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another site, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The legal version of this story can be viewed at www.tickerreport.com/banking-finance/3379591/analysts-set-state-bank-financial-stbz-pt-at-34-00.html.

    State Bank Financial Company Profile

Top 10 Blue Chip Stocks To Invest In Right Now: SmartFinancial, Inc.(SMBK)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on SmartFinancial (SMBK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Blue Chip Stocks To Invest In Right Now: Enersis S A(ENI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    HSBC set a €18.20 ($21.16) price objective on ENI (ETR:ENI) in a research note published on Monday morning. The brokerage currently has a buy rating on the stock.

  • [By Stephan Byrd]

    Deutsche Bank set a €18.50 ($21.51) price target on ENI (ETR:ENI) in a report released on Thursday. The brokerage currently has a buy rating on the stock.

  • [By Joseph Griffin]

    Headlines about Enel Americas (NYSE:ENI) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Enel Americas earned a news sentiment score of 0.04 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 44.8569330191595 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top 10 Blue Chip Stocks To Invest In Right Now: AxoGen, Inc.(AXGN)

Advisors’ Opinion:

  • [By Lee Jackson]

    Jefferies started coverage on this top biotech/medtech firm last year with a Buy rating. AxoGen Inc. (NASDAQ: AXGN) offers surgical solutions for peripheral nerve injuries. It provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane.

  • [By Joseph Griffin]

    These are some of the media stories that may have impacted Accern’s analysis:

    Get AxoGen alerts:

    Analysts Anticipate AxoGen, Inc (AXGN) Will Announce Earnings of -$0.06 Per Share (americanbankingnews.com) The SVP Sales of AxoGen (NASDAQ: AXGN) is Selling Shares (analystratings.com) BRIEF-Axogen Inc Says On May 15, Board Elected CEO Zaderej To Succeed Grooms As Chairman (reuters.com) AxoGen, Inc (AXGN) SVP Shawn F. Mccarrey Sells 10,000 Shares (americanbankingnews.com) Global Nerve Repair Biomateria Market Report 2018-2023 -Axogen, Integra, Synovis, Collagen Matrix, Polyganics … (talkdailynews.com)

    AxoGen opened at $43.95 on Monday, Marketbeat reports. AxoGen has a fifty-two week low of $13.95 and a fifty-two week high of $46.00. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.81 and a current ratio of 3.32. The company has a market cap of $1.52 billion, a P/E ratio of -141.77 and a beta of -0.04.

  • [By Shane Hupp]

    AxoGen, Inc (NASDAQ:AXGN) – Analysts at William Blair raised their Q2 2018 earnings estimates for AxoGen in a research report issued on Monday, May 14th. William Blair analyst K. Krum now expects that the medical equipment provider will post earnings per share of ($0.04) for the quarter, up from their prior forecast of ($0.05). William Blair currently has a “Outperform” rating on the stock. William Blair also issued estimates for AxoGen’s Q4 2018 earnings at ($0.03) EPS and FY2018 earnings at ($0.25) EPS.

  • [By Lee Jackson]

    This is another biotech/medical technology that Jefferies started coverage on with a Buy rating late last year. AxoGen Inc. (NASDAQ: AXGN) offers surgical solutions for peripheral nerve injuries. The Company provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane.

Top 10 Blue Chip Stocks To Invest In Right Now: Knowles Corporation(KN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    These are some of the news articles that may have impacted Accern Sentiment’s scoring:

    Get Knowles alerts:

    Head to Head Contrast: Knowles (KN) vs. Sony (SNE) (americanbankingnews.com) Knowles (KN) Given Consensus Rating of “Hold” by Analysts (americanbankingnews.com) Four seniors nab scholarships from Siouxland Officials Association (siouxcityjournal.com) When is Who Dares Wins on BBC One tonight, how old is host Nick Knowles and how does the game show work? (thesun.co.uk) Local students learn the art of architecture (dailytidings.com)

    KN has been the subject of several research analyst reports. Craig Hallum restated a “buy” rating and set a $17.00 price target (down from $20.00) on shares of Knowles in a research report on Thursday, February 8th. Zacks Investment Research lowered Knowles from a “hold” rating to a “sell” rating in a research report on Wednesday, February 14th. ValuEngine lowered Knowles from a “hold” rating to a “sell” rating in a research report on Monday, April 2nd. JPMorgan Chase lowered their price target on Knowles from $16.00 to $13.50 and set a “neutral” rating for the company in a research report on Tuesday, April 24th. Finally, Lake Street Capital lowered their price target on Knowles from $19.00 to $17.00 and set a “buy” rating for the company in a research report on Thursday, February 8th. Three investment analysts have rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of $17.29.

  • [By Stephan Byrd]

    Sony (NYSE: SNE) and Knowles (NYSE:KN) are both consumer discretionary companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, profitability, analyst recommendations, risk and valuation.

  • [By Joseph Griffin]

    Liberty Mutual Group Asset Management Inc. lowered its stake in shares of Knowles (NYSE:KN) by 22.4% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,610 shares of the communications equipment provider’s stock after selling 5,088 shares during the period. Liberty Mutual Group Asset Management Inc.’s holdings in Knowles were worth $222,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Knowles (KN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Shares of Knowles Corporation (NYSE: KN) got a boost, shooting up 15 percent to $12.83 as the company reported Q1 results.

    SVB Financial Group (NASDAQ: SIVB) shares were also up, gaining 19 percent to $305.90 following strong quarterly results.

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
    Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
    DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
    eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
    Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
    SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
    Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
    Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
    Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
    ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
    Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
    Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
    Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M

Top 10 Blue Chip Stocks To Invest In Right Now: Midatech Pharma PLC(MTP)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    But before we show you our pick, here are the top 10 penny stocks to watch this week…

    Penny Stocks Current Share Price (as of Jan. 5) Jan. 2-5 Gain (as of Jan. 5)
    My Size Inc. (Nasdaq: MYSZ) $1.66 152.28%
    Cytori Therapeutics Inc. (Nasdaq: CYTX) $0.47 89.52%
    DelMar Pharmaceuticals Inc. (Nasdaq: DMPI) $1.675 58.02%
    CAS Medical Systems Inc. (Nasdaq: CASM) $1.09 55.71%
    China HGS Real Estate Inc. (Nasdaq: HGSH) $1.83 47.58%
    Aethlon Medical Inc. (Nasdaq: AEMD) $1.56 43.12%
    Midatech Pharma Plc. (Nasdaq: MTP) $1.23 43.01%
    Comstock Holding Cos. Inc. (Nasdaq: CHCI) $1.87 36.5%
    Cenveo Inc. (Nasdaq: CVO) $1.20 31.82%
    EV Energy Partners LP (Nasdaq: EVEP) $0.6844 31.62%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

  • [By Logan Wallace]

    News articles about Midatech Pharma (NASDAQ:MTP) have trended somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Midatech Pharma earned a coverage optimism score of 0.04 on Accern’s scale. Accern also gave press coverage about the company an impact score of 47.6134155747452 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Shane Hupp]

    Media stories about Midatech Pharma (NASDAQ:MTP) have trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Midatech Pharma earned a news sentiment score of 0.05 on Accern’s scale. Accern also gave press coverage about the company an impact score of 45.0428548550507 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Top 10 Blue Chip Stocks To Invest In Right Now: S&W Seed Company(SANW)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on S&w Seed (SANW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Alico (NASDAQ: ALCO) and S&W Seed (NASDAQ:SANW) are both small-cap consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends.

  • [By Ethan Ryder]

    S&w Seed (NASDAQ:SANW) – Equities researchers at B. Riley decreased their Q3 2019 earnings per share (EPS) estimates for S&w Seed in a research note issued to investors on Thursday, May 10th. B. Riley analyst S. Sherbetchyan now anticipates that the company will post earnings of $0.00 per share for the quarter, down from their previous forecast of $0.01. B. Riley has a “Buy” rating and a $5.50 price objective on the stock.

  • [By Logan Wallace]

    Alico (NASDAQ: ALCO) and S&W Seed (NASDAQ:SANW) are both small-cap consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, analyst recommendations and risk.

Top 10 Blue Chip Stocks To Invest In Right Now: Flanigan’s Enterprises Inc.(BDL)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st

Top 10 Stocks To Watch For 2018

Macy’s (M) stock was slammed after its Investor Meeting, as reports focused on its gross margin challenges. However, it appears that Macy’s comparable store sale performance has improved compared to previous months and it looks quite capable of reaching its sales guidance for the full year. I believe that the market is now viewing Macy’s too negatively, putting too much weight on a weak February (which was likely influenced by delayed tax refunds) that made its Q1 comps quite weak and also temporarily affected its gross margins.

Comparable Store Sales Trends

Macy’s indicated that its May YTD (February to May) comparable store sales (owned plus licensed) improved by around 1% from its Q1 comparable store sales. As May has historically represented around 24% to 25% of Macy’s sales in the first four months, this means that May’s comps need to be approximately 4% better than Q1 comps to improve May YTD comps by 1%.

Thus, May’s comps (owned plus licensed) are estimated to be -0.6%. Based on Macy’s comments about how March/April performed a bit over 1% better than Q1’s average, we can also estimate that Macy’s owned plus licensed comps were around -7.4% in February and -3.4% in March/April. This leads to an estimate of -2.5% comps for the March to May period.

Top 10 Stocks To Watch For 2018: S&P Smallcap 600(PH)

Advisors’ Opinion:

  • [By Charles Mizrahi, President and CEO, Hampton Investors, Inc.]

    Parker Hannifin (PH) generates strong revenue from its aerospace division, while its primary industrial segment is lagging.

    Overall, we like the company’s balanced portfolio. PH had solid order rates this past year with backlog of $3.6 billion between its industrial and aerospace segments.

Top 10 Stocks To Watch For 2018: Carnival Corporation(CUK)

Advisors’ Opinion:

  • [By Rick Munarriz]

    Carnival Corporation & plc (NYSE:CCL) (NYSE:CUK)shareholders have to be feeling pretty good these days. The stock hit yet another new high on Friday, and the stock is trading 13% higher so far in 2017.It’s been smooth sailing so far this year, but the first big test comes on Tuesday morning when the world’s largest cruise line operator reports financial results for its fiscal first quarter.

Top 10 Stocks To Watch For 2018: Universal Health Services, Inc.(UHS)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Universal Health Services (UHS) tumbled to the bottom of the S&P 500 today after BuzzFeed published an investigative story alleging that the company’s psychiatric hospitals put profits ahead of people.

    Getty Images

    Shares of Universal Health Services dropped 12% to$111.30 today, while the S&P 500 rose 1.3% to 2,241.35, a record high.

    Universal Health Services’ stock had been minding its business for most of the day–it was up 1.1% at $127.76 at 3:10 p.m. today–when the story by BuzzFeed’s Rosalind Adams went live. Here’s the gist:

    Millwood Hospital is part of Americas largest psychiatric hospital chain, Universal Health Services, or UHS. Its more than 200 psychiatric facilities across the country admitted nearly 450,000 patients last year. The result was almost $7.5 billion in revenues from inpatient care last year and profit margins of around 30%. More than a third of the companys overall revenue from both medical hospitals and psychiatric facilities comes from taxpayers through Medicare and Medicaid.

    A yearlong BuzzFeed News investigation based on interviews with 175 current and former UHS staff, including 18 executives who ran UHS hospitals; more than 120 additional interviews with patients, government investigators, and other experts; and a cache of internal documents raises grave questions about the extent to which those profits were achieved at the expense of patients.

    Universal Health Services market capitalization dropped to $10.7 billion today from $12.3 billion yesterday. It reported net income of $680 million on sales of $9 billion in 2015.

  • [By Ben Levisohn]

    Universal Health Services (UHS) slumped to the bottom of the S&P 500 today after getting downgraded by Raymond James.

    Pixabay

    Universal Health Servicesdropped 6.8% to $101.55 today, while the S&P 500 fell 0.8% to 2,253.28.

    Raymond James analyst John Ransom and team explain why they cut Universal Health Services to Market Perform from Outperform:

    We are lowering our rating onUniversal Health Services to a Market Perform (from an Outperform) due to an escalation in events surrounding last weeks Buzzfeed article. Last Friday (12/9), Senator Grassley, Chair of the Judiciary Committee, sent a letter…to the office of inspector general regarding details of the current federal investigation into Universal Health Services. Specifically, the letter rehashes the Buzzfeed article and requests an update on the investigation by Dec. 23. Our view is that – even ifUniversal Health Services management is correct on the legalities – we think the entrance of the venerable Senator Grassley into the mix takes the political risk to a more dangerous level. Plus – even if “suicide ideation” doesn’t generate additional revenues per admission, we think it’s possible that the heightened political scrutiny could invite more caution and/or red tape into the admissions process – either externally or from self-policing. Add in the ongoing OIG investigation, and we think the risk-reward is no longer compelling.

    Universal Health Services’ market capitalization fell to $9.8 billion today from $10.6 billion yesterday. It reported net income of $680 million on sales of $9 billion in 2015.

  • [By Ben Levisohn]

    Universal Health Services (UHS), yesterday’s biggest loser, soared to the top of the S&P 500 today as it rebounded from the massive selloff.

    Agence France-Presse/Getty Images

    Universal Health Servicesgained 6.9% to $108.57 today, while the S&P 500 rose 0.4% to 2,262.03.

    Weakness in Universal Health Services began when Buzzfeed ran an article last week, contending the companys psychiatric hospitals put profits ahead of people. Yesterday, it tumbled when Raymond James cut its rating on the stock due to problems that could be caused by a potential Senate investigation.

    Universal Health Services’ market capitalization rose to $10.5 today from $9.8 billion yesterday, nearly recouping its drop from $10.6 billion on Dec. 13.

    It reported net income of $680 million on sales of $9 billion in 2015.

  • [By Benzinga News Desk]

    Goldman Sachs (NYSE: GS) has at least one billion reasons to hope President Trump’s paring back of Dodd-Frank will include the Volcker Rule: Link

    ECONOMIC DATA
    10:30 a.m. Dallas Fed Manufacturing Business Index
    11:30 a.m. 6-Month Bill Auction
    11:30 a.m. 3-Month Bill Auction
    1 p.m. 2-Year Note Auction
    1:15 p.m. Chicago Fed President Evans Speaks
    6:30 p.m. FOMC Member Kaplan Speaks
    ANALYST RATINGS
    Piper Jaffray upgraded Best Buy Co (NYSE: BBY) from Neutral to Overweight
    Wells Fargo upgraded Allscripts Healthcare (NASDAQ: MDRX) from Market Perform to Outperform
    Mizuho upgraded Universal Health Service (NYSE: UHS) from Neutral to Buy
    Piper Jaffray downgraded The Michaels Companies (NASDAQ: MIK) from Overweight to Neutral
    JMP Securities downgraded KB Home (NYSE: KBH) from Market Outperform to Market Perform
    Raymond James downgraded Sierra Wireless Inc. (NASDAQ: SWIR) from Outperform to Market Perform

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By David Zeiler]

    Fear that expense could return if Obamacare is repealed hammered hospital stocks on Nov. 9. HCA Holdings Inc. (NYSE: HCA) fell almost 11%. Universal Health Services Inc. (NYSE: UHS) slipped nearly 7%. And Tenet Healthcare Corp. (NYSE: THC) plummeted almost 25%.

  • [By Paul Ausick]

    Universal Health Services Inc. (NYSE: UHS) lost 8.4% Wednesday to post a new 52-week low of $1/99.81 after closing Tuesday at $108.99. The 52-week high is $139.77. Volume of around 5.8 million was nearly 6 times the daily average of around 1 million shares traded. Raymond James downgraded the stock this morning on news of another request for information from the company related to a federal investigation.

Top 10 Stocks To Watch For 2018: Chuy's Holdings, Inc.(CHUY)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows El Pollo LoCo Holdings stabilizing over thepast two yearswhile potentialpeers like large cap Chipotle Mexican Grill, Inc (NYSE: CMG) andsmall capsFiesta Restaurant Group Inc (NASDAQ: FRGI) and Chuy’s Holdings Inc (NASDAQ: CHUY)have performed better in the past and appear to be in downtrends for the past 1 1/2 years:

  • [By Peter Graham]

    A long term performance chart shows El Pollo LoCo Holdings having fallen below its IPO price for retail investors, butsharesappear to have stabilized over the past year and a halfwhile potentialpeers like small capFiesta Restaurant Group Inc (NASDAQ: FRGI) and large cap Chipotle Mexican Grill, Inc (NYSE: CMG) have performed better in the past and small cap Chuy’s Holdings Inc (NASDAQ: CHUY) is moving sideways:

  • [By Peter Graham]

    A long term performance chart shows Del Taco Restaurants now outperforming Mexican restaurant stock peers such as mid cap Chipotle Mexican Grill, Inc (NYSE: CMG) and small caps El Pollo LoCo Holdings Inc (NASDAQ: LOCO), Fiesta Restaurant Group Inc (NASDAQ: FRGI) and Chuy’s Holdings Inc (NASDAQ: CHUY) have mostly been drifting lower lately:

  • [By Peter Graham]

    A long term performance chart shows Chipotle Mexican Grills shares back to breakeven while of the small caps peers, El Pollo LoCo Holdings Inc (NASDAQ: LOCO) has had the worst performance, Fiesta Restaurant Group Inc (NASDAQ: FRGI) is off its 2015s peak and Chuy’s Holdings Inc (NASDAQ: CHUY) has been a mixed performer:

Top 10 Stocks To Watch For 2018: Dow Treasuries(DV)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart of Apollo Education Group along with peersITT Educational Services, Inc (NYSE: ESI) and DeVry Education Group Inc (NYSE: DV) reflect the headwinds from the Obama administration:

Top 10 Stocks To Watch For 2018: Cara Therapeutics, Inc.(CARA)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Cara Therapeutics (CARA) , Verizon (VZ) , Radius Health (RDUS) and Six Flags (SIX) .

    Cramer was bearish on Hertz Global Holdings (HTZ) , General Motors (GM) , Pandora Media (P) , Cedar Fair (FUN) , Quotient Technology (QUOT) and Rite Aid (RAD) .

  • [By Javier Hasse]

    On the other hand, Cara Therapeutics Inc (NASDAQ: CARA) was up almost 1.9 percent in what also looked like a correction of the 1.6 percent gain registered over the regular trading session.

Top 10 Stocks To Watch For 2018: Voyager Therapeutics, Inc.(VYGR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Voyager Therapeutics Inc (NASDAQ: VYGR) got a boost, shooting up 20 percent to $13.10 after the company announced 'positive' results from ongoing Phase 1b trial of VY-AADC01 for advanced Parkinson's disease.

Top 10 Stocks To Watch For 2018: NanoString Technologies, Inc.(NSTG)

Advisors’ Opinion:

  • [By Lisa Levin]

    NanoString Technologies Inc (NASDAQ: NSTG) was down, falling around 21 percent to $18.06 after the company issued weak revenue forecast for FY2016.

Top 10 Stocks To Watch For 2018: Midatech Pharma PLC(MTP)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    But before we show you our pick, here are the top 10 penny stocks to watch this week…

    Penny Stocks Current Share Price (as of Jan. 5) Jan. 2-5 Gain (as of Jan. 5)
    My Size Inc. (Nasdaq: MYSZ) $1.66 152.28%
    Cytori Therapeutics Inc. (Nasdaq: CYTX) $0.47 89.52%
    DelMar Pharmaceuticals Inc. (Nasdaq: DMPI) $1.675 58.02%
    CAS Medical Systems Inc. (Nasdaq: CASM) $1.09 55.71%
    China HGS Real Estate Inc. (Nasdaq: HGSH) $1.83 47.58%
    Aethlon Medical Inc. (Nasdaq: AEMD) $1.56 43.12%
    Midatech Pharma Plc. (Nasdaq: MTP) $1.23 43.01%
    Comstock Holding Cos. Inc. (Nasdaq: CHCI) $1.87 36.5%
    Cenveo Inc. (Nasdaq: CVO) $1.20 31.82%
    EV Energy Partners LP (Nasdaq: EVEP) $0.6844 31.62%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

Top 10 Stocks To Watch For 2018: Big 5 Sporting Goods Corporation(BGFV)

Advisors’ Opinion:

  • [By Nicholas Rossolillo]

    Dick’s Sporting Goods (NYSE:DKS) and Big 5 Sporting Goods (NASDAQ:BGFV) have both had a great 2016. As far as stock performance goes, Big 5 is the winner this year. But which company is in better shape for the new year?